Director of Relmada Therapeutics, Inc. (NASDAQ:RLMD), Kelly Paul Edward, sells 2,069 shares worth $73,005
According to Relmada Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 07:25 PM, company Director, Kelly Paul Edward disclosed selling 2,069 shares at a cost of $35.29. At the time of this transaction (Feb 09), this trade was worth $73,005 in total. As of Feb 09, Kelly Paul Edward now owns 162,295 shares in total worth about $5,672,210.25.
For the last few recent trades made by Relmada Therapeutics, Inc. (NASDAQ:RLMD) Director, Kelly Paul Edward, we have the following information:
- SEC Form 4 filing: Feb 08: Sold 1,500 shares at the rate of $35.04 per share. Total worth of this trade was $52,560. Total number of shares owned as of Feb 08 were 164,364
- SEC Form 4 filing: Feb 01: Sold 31 shares at the rate of $35.00 per share. Total worth of this trade was $1,085. Total number of shares owned as of Feb 01 were 164,610
- SEC Form 4 filing: Feb 02: Sold 2,315 shares at the rate of $35.04 per share. Total worth of this trade was $81,118. Total number of shares owned as of Feb 02 were 162,295
Posted by
George Daniels
on Wednesday February 10 2021, 10:50 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
